{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:19:38Z","timestamp":1791047978336,"version":"4.1.0"},"reference-count":76,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therap Adv Gastroenterol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Despite the availability of various advanced treatments for inflammatory bowel disease (IBD), it has been impossible to predict which therapy would offer the best response to the patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The aim of this systematic review is to explore current and novel biomarkers for predicting and assessing therapeutic response to advanced therapies presently in clinical use in IBD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PROSPERO ID: CRD42024559652). A systematic literature search for all primary research looking at biomarkers in predicting response to advanced therapy in Crohn\u2019s disease (CD) or ulcerative colitis (UC) was conducted across MEDLINE, EMBASE and PubMed databases. Abstracts, case studies, commentary papers and review articles were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Fifty-five studies were included in this review investigating baseline predictors of response to anti-tumour necrosis factor, ustekinumab, vedolizumab and ozanimod therapies in both CD and UC. The various biomarkers studied included blood, serum, faecal, histological, nutrient, genetic and pharmacokinetic markers. C-reactive protein and faecal calprotectin were among the most commonly studied biomarkers; however, there were inconsistencies with regard to optimum cutoff values used and hence their roles as baseline predictors of response to advanced therapies are yet unclear. None of the biomarker studies to date has yet transitioned to clinical use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Biomarker identification to predict therapeutic response persists to be an ongoing challenge. Further work through large well-designed prospective cohort studies is needed to further refine the clinical utility of these tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">The protocol was prospectively registered with the PROSPERO database (CRD42024559652)<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562848261463913","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:53:28Z","timestamp":1783922008000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Current and novel biomarkers for predicting and assessing therapeutic response in inflammatory bowel disease: a systematic review"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2226-0810","authenticated-orcid":false,"given":"Shellie","family":"Radford","sequence":"first","affiliation":[{"name":"NIHR Biomedical Research Centre, Liver and GI Team, Queens Medical Centre, E Floor, West Block, Nottingham NG7 5UH, UK"},{"name":"School of Medicine, The University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"John","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Nottingham, Nottingham, UK"},{"name":"Nottingham NIHR Biomedical Research Centre, Liver and GI Disorder\u2019s Theme, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Latino-Kelly","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Alexander","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Wilding","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimin","family":"Chauhan","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Shokraneh","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Department, Systematic Review Consultants Ltd, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhee","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Nottingham NIHR Biomedical Research Centre, Liver and GI Disorder\u2019s Theme, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-6908","authenticated-orcid":false,"given":"Gordon W.","family":"Moran","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Nottingham, Nottingham, UK"},{"name":"Nottingham NIHR Biomedical Research Centre, Liver and GI Disorder\u2019s Theme, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0528"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00551"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-334395"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaf276"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-065186"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.120"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-073639"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-105790"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-D-19-00099"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa062"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01253-8"},{"issue":"2","key":"e_1_3_4_14_2","first-page":"2020","article-title":"Functional molecular network analysis enables prediction of response to vedolizumab therapy in anti-TNF refractory IBD patients","volume":"360","author":"Breidert M","unstructured":"Breidert M, et al. Functional molecular network analysis enables prediction of response to vedolizumab therapy in anti-TNF refractory IBD patients. Crohns Colitis 360 2020; 2(2): otaa037.","journal-title":"Crohns Colitis"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48651-y"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-024-08391-z"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000508069"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15870"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000515361"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2017.1403647"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz195"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2010.539253"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izx103"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2021.00049"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2018-000208"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.654319"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16151"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305324"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-80285-6"},{"issue":"3","key":"e_1_3_4_30_2","first-page":"407","article-title":"Predictors of the efficacy of vedolizumab in patients with ulcerative colitis","volume":"86","author":"Kajikawa G","year":"2024","unstructured":"Kajikawa G, et al. Predictors of the efficacy of vedolizumab in patients with ulcerative colitis. Nagoya J Med Sci 2024; 86(3): 407\u2013421.","journal-title":"Nagoya J Med Sci"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2025.00047"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S500600"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i19.2354"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2016.1205128"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000273"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105369"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000515432"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000605"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy304"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S497655"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13081941"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02120-17"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae064"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000547013"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01601-6"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz222"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000445"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.178665"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx091"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.01.027"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad170"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac233"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01819-7"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(25)00102-5"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i31.4481"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000635"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1177\/17562848251353293"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-022-04176-w"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020459"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu16020280"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13936"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu15010240"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab114"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820971214"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy307"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy272"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpph.19"},{"issue":"4","key":"e_1_3_4_68_2","first-page":"2020","article-title":"Tolerability of bowel preparation and colonoscopy in IBD patients: results from a prospective, single-center, case-control study","volume":"360","author":"Bezzio C","unstructured":"Bezzio C, et al. Tolerability of bowel preparation and colonoscopy in IBD patients: results from a prospective, single-center, case-control study. Crohns Colitis 360 2020; 2(4): otaa077.","journal-title":"Crohns Colitis"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1177\/17562848241251600"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.09.029"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.12.007"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaf106"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2018.00114"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2907-3"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.120065"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.12.245"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.01.026"}],"container-title":["Therapeutic Advances in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848261463913","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562848261463913","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848261463913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:47:32Z","timestamp":1784184452000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562848261463913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":76,"alternative-id":["10.1177\/17562848261463913"],"URL":"https:\/\/doi.org\/10.1177\/17562848261463913","relation":{},"ISSN":["1756-2848","1756-2848"],"issn-type":[{"value":"1756-2848","type":"print"},{"value":"1756-2848","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"article-number":"17562848261463913"}}